Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.480
-0.010 (-0.41%)
Nov 21, 2024, 12:22 PM EST - Market open
Palisade Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 8.04 | 12.43 | 12.38 | 10.5 | 0.71 | 3.6 | Upgrade
|
Short-Term Investments | - | - | - | - | 0.02 | - | Upgrade
|
Cash & Short-Term Investments | 8.04 | 12.43 | 12.38 | 10.5 | 0.73 | 3.6 | Upgrade
|
Cash Growth | -47.49% | 0.40% | 17.99% | 1339.64% | -79.73% | 861.76% | Upgrade
|
Other Receivables | - | 0.15 | 1.44 | 0.15 | 0.06 | - | Upgrade
|
Receivables | - | 0.15 | 1.44 | 0.15 | 0.06 | - | Upgrade
|
Prepaid Expenses | 0.83 | 0.64 | 0.8 | 0.86 | 0.07 | 0.12 | Upgrade
|
Other Current Assets | - | 0.11 | 0.11 | - | 0.04 | - | Upgrade
|
Total Current Assets | 8.87 | 13.33 | 14.73 | 11.51 | 0.9 | 3.72 | Upgrade
|
Property, Plant & Equipment | 0.12 | 0.21 | 0.31 | 0.11 | 0.28 | 0.42 | Upgrade
|
Long-Term Deferred Charges | - | - | - | - | 1.82 | - | Upgrade
|
Other Long-Term Assets | 0.35 | 0.52 | 0.72 | 0.89 | 0.03 | 0.03 | Upgrade
|
Total Assets | 9.34 | 14.05 | 15.76 | 12.51 | 3.02 | 4.17 | Upgrade
|
Accounts Payable | 0.37 | 0.7 | 1.76 | 1.32 | 2.54 | 2.05 | Upgrade
|
Accrued Expenses | 1.96 | 1.61 | 1.06 | 0.97 | 4.33 | 0.43 | Upgrade
|
Current Portion of Long-Term Debt | 0.24 | 0.16 | 0.09 | 0.09 | 1.05 | 0.1 | Upgrade
|
Current Portion of Leases | 0.12 | 0.12 | 0.11 | 0.11 | 0.17 | 0.14 | Upgrade
|
Total Current Liabilities | 2.68 | 2.59 | 3.01 | 2.5 | 8.08 | 2.72 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.09 | - | Upgrade
|
Long-Term Leases | - | 0.09 | 0.21 | - | 0.11 | 0.28 | Upgrade
|
Other Long-Term Liabilities | 0.05 | 0.06 | 0.06 | 2.65 | 1.83 | - | Upgrade
|
Total Liabilities | 2.73 | 2.74 | 3.28 | 5.15 | 10.12 | 3 | Upgrade
|
Common Stock | 0.01 | 0.09 | 0.03 | 0 | 0.03 | 0.1 | Upgrade
|
Additional Paid-In Capital | 139.2 | 132.72 | 121.64 | 102 | 51.4 | 49.27 | Upgrade
|
Retained Earnings | -132.6 | -121.51 | -109.19 | -94.64 | -68.03 | -57.7 | Upgrade
|
Total Common Equity | 6.61 | 11.31 | 12.48 | 7.36 | -16.6 | -8.33 | Upgrade
|
Shareholders' Equity | 6.61 | 11.31 | 12.48 | 7.37 | -7.1 | 1.17 | Upgrade
|
Total Liabilities & Equity | 9.34 | 14.05 | 15.76 | 12.51 | 3.02 | 4.17 | Upgrade
|
Total Debt | 0.36 | 0.37 | 0.4 | 0.2 | 1.42 | 0.52 | Upgrade
|
Net Cash (Debt) | 7.68 | 12.06 | 11.98 | 10.3 | -0.69 | 3.08 | Upgrade
|
Net Cash Growth | -48.14% | 0.70% | 16.35% | - | - | - | Upgrade
|
Net Cash Per Share | 7.45 | 26.45 | 204.12 | 826.06 | - | 25.10 | Upgrade
|
Filing Date Shares Outstanding | 1.33 | 0.85 | 0.3 | 0.02 | 102.04 | 102.03 | Upgrade
|
Total Common Shares Outstanding | 1.2 | 0.62 | 0.2 | 0.02 | 102.04 | 102.03 | Upgrade
|
Working Capital | 6.19 | 10.74 | 11.72 | 9.01 | -7.19 | 1.01 | Upgrade
|
Book Value Per Share | 5.51 | 18.30 | 63.57 | 387.81 | -0.16 | -0.08 | Upgrade
|
Tangible Book Value | 6.61 | 11.31 | 12.48 | 7.36 | -16.6 | -8.33 | Upgrade
|
Tangible Book Value Per Share | 5.51 | 18.30 | 63.57 | 387.81 | -0.16 | -0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.